| Literature DB >> 18555712 |
Javier Millán1, Mónica G Candela, Francisco Palomares, María José Cubero, Alejandro Rodríguez, Marta Barral, José de la Fuente, Sonia Almería, Luis León-Vizcaíno.
Abstract
The Iberian lynx, (Lynx pardinus), is the most endangered felid in the world. To determine whether sympatric carnivores are reservoirs of pathogens posing a disease risk for the lynx, evidence of exposure to 17 viral, bacterial and protozoan agents was investigated in 176 carnivores comprising 26 free-living lynx, 53 domestic cats, 28 dogs, 33 red foxes (Vulpes vulpes), 24 Egyptian mongooses (Herpestes ichneumon), 10 common genets (Genetta genetta) and 2 Eurasian badgers (Meles meles) in the areas inhabited by the last two populations of Iberian lynx, both in Andalusia (South-Western Spain). The results indicated that the lynx had low rates of contact with viral pathogens, with one seropositive finding each for feline leukemia virus, parvovirus and canine adenovirus-1, whereas contact with bacteria and protozoa appeared more frequent. Active infections with parvovirus, Ehrlichia spp., Mycobacterium bovis, Leptospira interrogans and Cytauxzoon spp. were confirmed. In contrast, 53% of the domestic cats were exposed to some infectious agent (prevalence range 4.5-11.4%). Antibodies to canine distemper virus and parvovirus were frequently found in dogs (32% and 42%, respectively) and foxes (30% and 12%). Past or present infections with parvovirus, Ehrlichia spp., Chlamydophila spp., M. bovis, Salmonella enterica, L. interrogans, Toxoplasma gondii, and Neospora caninum were also detected in these and other species surveyed. Questionnaires to owners revealed that 14% of the dogs but none of the cats had been vaccinated, and no cat had been neutered. Based on the apparent absence of acquired immunity of the lynx against infectious agents, the frequent detection of agents among sympatric carnivores, and the reported lack of immunocompetence of the Iberian lynx, a disease outbreak among the local abundant carnivores may pose a serious disease risk for lynx conservation.Entities:
Mesh:
Year: 2008 PMID: 18555712 PMCID: PMC7129241 DOI: 10.1016/j.tvjl.2008.04.005
Source DB: PubMed Journal: Vet J ISSN: 1090-0233 Impact factor: 2.688
Fig. 1Map of the study areas where Iberian lynx and other sympatric carnivores were studied for exposure against infectious and protozoan pathogens. Approximate lynx distributions areas are adapted from Guzmán et al. (2004). Locations of samples with exact known origin are shown with symbols representing the different species surveyed. Sample size is given into the symbols.
Sample size and origin of the animals sampled for diseases surveillance in the Iberian lynx distribution areas (Spain) during 2004–2006
| Sierra Morena | Doñana | Total | |||||
|---|---|---|---|---|---|---|---|
| In vivo | Post-mortem | Total | In vivo | Post-mortem | Total | ||
| Iberian lynx | 9 | 3 | 11 | 13 | 5 | 15 | 26 |
| Domestic cat | 20 | 10 | 30 | 10 | 13 | 23 | 53 |
| Dog | 19 | 19 | 9 | 9 | 28 | ||
| Red fox | 17 | 21 | 33 | 33 | |||
| Egyptian mongoose | 21 | 9 | 24 | 24 | |||
| Common genet | 7 | 3 | 10 | 10 | |||
| Eurasian badger | 2 | 2 | 2 | ||||
Some animals were surveyed alive and later subjected to post-mortem examination.
Summary of methodologies used to detect evidence of contact with disease agents in carnivores in the Iberian lynx distribution areas during 2004–2006, showing samples analysed, threshold for serology (if quantitative), sequences used for polymerase chain reaction (PCR), conjugates used for immunofluorescence, and media used for culture
| Agent | Sample | Assay | Detects | Name of commercial kits, positive cut-off (serology), sequences (PCR), conjugates (FA), and media (culture) | Manufacturers (in parenthesis) and/or references |
|---|---|---|---|---|---|
| FCV | Serum | cELISA | c | F1008-AB02 Feline Calicivirus ELISA | Eurovet Veterinaria |
| FHV-1 | Serum | cELISA | c | F107-AB02 Feline Herpes ELISA | Eurovet Veterinaria |
| Oro-pharyngeal swab | FA | ai | Feline serum anti-FHV-1 | Eurovet Veterinaria | |
| 210-41-FHV/FVR | VMRD | ||||
| FCoV | Serum | cELISA | c | Ingezim Corona Felino | Ingenasa |
| Enteric mucosa, mesenteric LN, faeces | FA | ai | Feline serum anti-FCoV | Ingenasa | |
| Anti-felineIgG FITC conjugate | VMRD | ||||
| RIC | ai | FCoVMegacor (FB995) | VMRD | ||
| FeLV | Serum | cELISA | c | Ingezim FeLV | Ingenasa |
| Serum | ELISA-d | ai | Ingezim FeLV-Das | Ingenasa | |
| FIV | Serum | cELISA | c | Ingezim FIV | Ingenasa |
| PV | Serum | cELISA | c | Ingezim CPV | Ingenasa |
| Intestine, intestinal content, faeces | PCR | ai | BAD 1017A | Eurokit S.L. | |
| VPF (5’-GAT GGC ACC TCC GGC AAA GA-3’) | |||||
| VPR (5’-TTT CTA GGT GCT AGT TGA G-3’) | |||||
| ELISA-d | ai | Ingezim CPV/FPV-Das | Ingenasa | ||
| IPo | ai | Rabbit IgG anti-feline panleukopenia virus 29989 ImmunoPure biotinylated protein A. 21123 ImmunoPure Avidin, Horseradish peroxidase conjugate | Pierce Chemical Co., | ||
| FA | ai | Feline serum anti-FPV | Ingenasa | ||
| Anti-feline IgG FITC conjugate | VMRD | ||||
| CDV | Serum | cELISA | c | Ingezim Moquillo | Ingenasa |
| Tonsils, retro-pharyngeal and/or submandibular LN | FA | ai | Canine serum anti-CDV | Ingenasa | |
| Anti-canine IgG FITC conjugate | VMRD | ||||
| PCR | ai | Ingene CDV | Ingenasa | ||
| CAV-1 | Serum | cELISA | c | Canine hepatitis IgG ELISA | Eurovet Veterinaria |
| Tonsils, retro-pharyngeal and/or submandibular LN | FA | ai | Canine serum anti-CAV-1 | Eurovet Veterinaria | |
| Anti-canine IgG FITC conjugate | VMRD | ||||
| EH | Serum | cELISA | c | Ingezim | Ingenasa |
| Spleen | FA | ai | Canine serum positive to | VMRD | |
| Ref-211-P-EC Rabbit anti-dog IgG Fc fragment antibody, FITC conjugated | Rockland Immunochemicals | ||||
| CH | Serum | cELISA | c | Eurovet Veterinaria | |
| Conjunctival swab | RIC | ai | Clearview | Unipath | |
| LI | Serum | MAL | c | 1:100 | |
| Kidney and/or urine | Staining | ai | Argentic stain | ||
| IPo + IFA | ai | Ig Rabbit anti | Nordic Immunological Laboratories, | ||
| Culture | ai | EMJH medium | Difco Laboratories | ||
| BB | Tonsil smears | FA | ai | Serum anti | Institut Pasteur Production VMRD, |
| Anti-canine IgG FITC | |||||
| SE | Multiorgan | Culture | ai | Selenite-cystine and Rappaport-Vassiliadis + Salmonella-Shigella agar and brilliant green agar | |
| MB | Serum | cELISA | c | Protein MBP70; ⩾30% | |
| Multiorgan | Culture | ai | Middlebrook’s 7H11 and Lowenstein-Jensen media | ||
| PCR | ai | TB1-F (5´-GAA CAA TCC GCA GTT GAC AA-3´) | |||
| TB1-R (5´-AGC ACG CTG TCA ATC ATG TA-3´) | |||||
| TG | Serum | MAT | c | 1:25 | |
| Faeces | FA | ai | Toxo-Troll ‘F’ 75 411 | BioMérieux Industry | |
| NC | Serum | ELISA + IFA | c | >40% | VMRD |
| CF | Entire blood | PCR | ai | 7549 (5´-GTCAGGATCCTGGGTTGATCCTGCCAG-3´) | |
| 7548 (5´-GACTGAATTCGACTTCTCCTTCCTTTAAG-3´) |
FCV, feline calicivirus; FHV-1, feline herpesvirus-1; FCoV, feline coronavirus; FeLV, feline leukemia virus; FIV, feline immunodeficiency virus; PV, feline parvovirus subgroup virus; CDV, canine distemper virus; CAV-1, canine adenovirus-1; EH, Ehrlichia spp.; CH, Chlamydophila spp.; LI, Leptospira interrogans (serovars Australis, Autumnalis, Ballum, Bataviae, Bratislava, Canicola, Grippotyphosa, Hardjo, Hebdomadis, Icterogaemorrhagiae, Pomona, Saxkoebing, Sejroë, Tarassovi); BB, Borrelia burgdorferi; SE, Salmonella enterica; MB, Mycobacterium bovis; TG, Toxoplasma gondii; NC, Neospora caninum; CF, Cytauxzoon felis.
LN, lymph node.
ELISA, enzyme-linked immunosorbent assay (c, competitive; d, direct); FA, direct immunofluorescence; IFA, indirect immunofluorescence assay; IPo, immunoperoxidase; LA, latex aglutination; MAL, microaglutination-lisis; MAT, modified agglutination test; RIC, rapid immunochromatography.
ai, active infection; c, contact with the agent.
Fig. 2Results of the survey for pathogens in Iberian lynx (Lp), domestic cat (Fc), dog (Cf), red fox (Vv), Egyptian mongoose (Hi), common genet (Gg) and Eurasian badger (Mm) in lynx areas. Black columns: evidences of contact with the agent; white columns: detection of active infections. Sample size is shown in the top of the column (absence of data means that no animal was analysed). See Table 2 and text for further details.